Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 312.50 | 138.75 | 292.00 | 243.50 | 1.1992 | 1.5018 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 312.50 | 138.75 | 249.00 | 243.50 | 1.0226 | 1.0558 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 312.50 | 138.75 | 291.00 | 243.50 | 1.1951 | 1.4912 |
| SK-BR-3 | Etoposide | 0.0033113 | uM | 5 | 312.50 | 138.75 | 258.00 | 243.50 | 1.0595 | 1.1478 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 312.50 | 138.75 | 254.00 | 243.50 | 1.0431 | 1.1068 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 312.50 | 138.75 | 184.00 | 243.50 | 0.7557 | 0.4160 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 138.75 | 801.00 | 243.50 | 3.2895 | 7.6764 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 312.50 | 138.75 | 266.00 | 243.50 | 1.0924 | 1.2301 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 312.50 | 138.75 | 322.00 | 243.50 | 1.3224 | 1.8222 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 312.50 | 138.75 | 238.00 | 243.50 | 0.9774 | 0.9445 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 312.50 | 138.75 | 298.00 | 243.50 | 1.2238 | 1.5653 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 312.50 | 138.75 | 787.00 | 243.50 | 3.2320 | 7.4899 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 312.50 | 138.75 | 321.00 | 243.50 | 1.3183 | 1.8114 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 312.50 | 138.75 | 138.00 | 243.50 | 0.5667 | -0.0067 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 239.00 | 243.50 | 0.9815 | 0.9546 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 244.00 | 243.50 | 1.0021 | 1.0051 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 165.00 | 243.50 | 0.6776 | 0.2381 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 221.00 | 243.50 | 0.9076 | 0.7748 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 312.50 | 138.75 | 146.00 | 243.50 | 0.5996 | 0.0648 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 312.50 | 138.75 | 227.00 | 243.50 | 0.9322 | 0.8343 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 294.00 | 243.50 | 1.2074 | 1.5229 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 5 | 312.50 | 138.75 | 125.00 | 243.50 | 0.5134 | -0.1207 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 312.50 | 138.75 | 235.00 | 243.50 | 0.9651 | 0.9143 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 312.50 | 138.75 | 241.00 | 243.50 | 0.9897 | 0.9747 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 312.50 | 138.75 | 229.00 | 243.50 | 0.9405 | 0.8543 |